{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T21:17:29Z","timestamp":1775683049744,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ20G030015"],"award-info":[{"award-number":["LQ20G030015"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health Commission of Zhejiang Province","award":["2020KY201"],"award-info":[{"award-number":["2020KY201"]}]},{"DOI":"10.13039\/501100020777","name":"Zhejiang Pharmaceutical Association","doi-asserted-by":"publisher","award":["2022ZYJ14"],"award-info":[{"award-number":["2022ZYJ14"]}],"id":[{"id":"10.13039\/501100020777","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s10067-022-06377-8","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T15:02:41Z","timestamp":1663599761000},"page":"15-27","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Bibliometric analysis of IgG4-related disease research from 2003 to 2022 based on Web of Science Core Collection Databases"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5275-6596","authenticated-orcid":false,"given":"Zhijie","family":"Lv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8469-514X","authenticated-orcid":false,"given":"Li","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5618-6364","authenticated-orcid":false,"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9139-3257","authenticated-orcid":false,"given":"Shan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5176-3719","authenticated-orcid":false,"given":"Qiushuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,19]]},"reference":[{"key":"6377_CR1","doi-asserted-by":"publisher","first-page":"m1067","DOI":"10.1136\/bmj.m1067","volume":"369","author":"M Lanzillotta","year":"2020","unstructured":"Lanzillotta M, Mancuso G, Della-Torre E (2020) Advances in the diagnosis and management of IgG4 related disease. BMJ 369:m1067. https:\/\/doi.org\/10.1136\/bmj.m1067","journal-title":"BMJ"},{"issue":"10","key":"6377_CR2","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","volume":"38","author":"T Kamisawa","year":"2003","unstructured":"Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, Okamoto A, Egawa N, Nakajima H (2003) A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 38(10):982\u2013984. https:\/\/doi.org\/10.1007\/s00535-003-1175-y","journal-title":"J Gastroenterol"},{"issue":"9","key":"6377_CR3","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/art.39205","volume":"67","author":"ZS Wallace","year":"2015","unstructured":"Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, Pillai S, Stone JH (2015) IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol 67(9):2466\u20132475. https:\/\/doi.org\/10.1002\/art.39205","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"6377_CR4","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s00535-019-01658-7","volume":"55","author":"A Masamune","year":"2020","unstructured":"Masamune A, Kikuta K, Hamada S, Tsuji I, Takeyama Y, Shimosegawa T, Okazaki K, Collaborators (2020) Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016. J Gastroenterol 55(4):462\u2013470. https:\/\/doi.org\/10.1007\/s00535-019-01658-7","journal-title":"J Gastroenterol"},{"issue":"6","key":"6377_CR5","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/MPA.0b013e3182480c99","volume":"41","author":"A Kanno","year":"2012","unstructured":"Kanno A, Nishimori I, Masamune A, Kikuta K, Hirota M, Kuriyama S, Tsuji I, Shimosegawa T, Research Committee on Intractable Diseases of P (2012) Nationwide epidemiological survey of autoimmune pancreatitis in Japan. Pancreas 41(6):835\u2013839. https:\/\/doi.org\/10.1097\/MPA.0b013e3182480c99","journal-title":"Pancreas"},{"issue":"6","key":"6377_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMra1104650","volume":"366","author":"JH Stone","year":"2012","unstructured":"Stone JH, Zen Y, Deshpande V (2012) IgG4-related disease. N Engl J Med 366(6):539\u2013551. https:\/\/doi.org\/10.1056\/NEJMra1104650","journal-title":"N Engl J Med"},{"key":"6377_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2147\/TCRM.S99985","volume":"12","author":"D Lang","year":"2016","unstructured":"Lang D, Zwerina J, Pieringer H (2016) IgG4-related disease: current challenges and future prospects. Ther Clin Risk Manag 12:189\u2013199. https:\/\/doi.org\/10.2147\/TCRM.S99985","journal-title":"Ther Clin Risk Manag"},{"key":"6377_CR8","doi-asserted-by":"publisher","first-page":"100074","DOI":"10.1016\/j.jtauto.2020.100074","volume":"4","author":"A Floreani","year":"2021","unstructured":"Floreani A, Okazaki K, Uchida K, Gershwin ME (2021) IgG4-related disease: changing epidemiology and new thoughts on a multisystem disease. J Transl Autoimmun 4:100074. https:\/\/doi.org\/10.1016\/j.jtauto.2020.100074","journal-title":"J Transl Autoimmun"},{"issue":"12","key":"6377_CR9","doi-asserted-by":"publisher","first-page":"e1918007","DOI":"10.1001\/jamanetworkopen.2019.18007","volume":"2","author":"JS Brandt","year":"2019","unstructured":"Brandt JS, Hadaya O, Schuster M, Rosen T, Sauer MV, Ananth CV (2019) A bibliometric analysis of top-cited journal articles in obstetrics and gynecology. JAMA Netw Open 2(12):e1918007. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.18007","journal-title":"JAMA Netw Open"},{"issue":"4","key":"6377_CR10","doi-asserted-by":"publisher","first-page":"e215840","DOI":"10.1001\/jamanetworkopen.2021.5840","volume":"4","author":"M Wilson","year":"2021","unstructured":"Wilson M, Sampson M, Barrowman N, Doja A (2021) Bibliometric analysis of neurology articles published in general medicine journals. JAMA Netw Open 4(4):e215840. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.5840","journal-title":"JAMA Netw Open"},{"issue":"4","key":"6377_CR11","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.21037\/apm-20-1978","volume":"10","author":"P Chen","year":"2021","unstructured":"Chen P, Lin X, Chen B, Zheng K, Lin C, Yu B, Lin F (2021) The global state of research and trends in osteomyelitis from 2010 to 2019: a 10-year bibliometric analysis. Ann Palliat Med 10(4):3726\u20133738. https:\/\/doi.org\/10.21037\/apm-20-1978","journal-title":"Ann Palliat Med"},{"issue":"10","key":"6377_CR12","doi-asserted-by":"publisher","first-page":"e0223994","DOI":"10.1371\/journal.pone.0223994","volume":"14","author":"C Chen","year":"2019","unstructured":"Chen C, Song M (2019) Visualizing a field of research: a methodology of systematic scientometric reviews. PLoS ONE 14(10):e0223994. https:\/\/doi.org\/10.1371\/journal.pone.0223994","journal-title":"PLoS ONE"},{"key":"6377_CR13","doi-asserted-by":"publisher","first-page":"705033","DOI":"10.3389\/fped.2021.705033","volume":"9","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, Kong HB, He BM, Zhou SY (2021) Bibliometric analysis of bronchopulmonary dysplasia in extremely premature infants in the Web of Science Database using CiteSpace Software. Front Pediatr 9:705033. https:\/\/doi.org\/10.3389\/fped.2021.705033","journal-title":"Front Pediatr"},{"key":"6377_CR14","unstructured":"Chen C (2016) CiteSpace: a practical guide for mapping scientific literature 2016."},{"key":"6377_CR15","doi-asserted-by":"publisher","unstructured":"Zhou F, Zhang T, Jin Y, Ma Y, Xian Z, Zeng M, Yu G (2022) Worldwide tinnitus research: a bibliometric analysis of the published literature between 2001 and 2020. Frontiers in Neurology.13https:\/\/doi.org\/10.3389\/fneur.2022.828299","DOI":"10.3389\/fneur.2022.828299"},{"issue":"7","key":"6377_CR16","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/asi.21309","volume":"61","author":"CM Chen","year":"2010","unstructured":"Chen CM, Ibekwe-SanJuan F, Hou JH (2010) The structure and dynamics of cocitation clusters: a multiple-perspective cocitation analysis. J Am Soc Inf Sci Tec 61(7):1386\u20131409. https:\/\/doi.org\/10.1002\/asi.21309","journal-title":"J Am Soc Inf Sci Tec"},{"key":"6377_CR17","unstructured":"Li J, Chen CM (2022) Citespace: text mining and visualization in scientific literature. 3rd ed: Beijing:Capital University of Economics and Business Press"},{"issue":"9","key":"6377_CR18","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, Kloppel G, Heathcote JG, Khosroshahi A, Ferry JA et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25(9):1181\u20131192. https:\/\/doi.org\/10.1038\/modpathol.2012.72","journal-title":"Mod Pathol"},{"issue":"1","key":"6377_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10165-011-0571-z","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Yoshino T, Nakamura S, Kawa S et al (2012) Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 22(1):21\u201330. https:\/\/doi.org\/10.1007\/s10165-011-0571-z","journal-title":"Mod Rheumatol"},{"issue":"9976","key":"6377_CR20","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","volume":"385","author":"T Kamisawa","year":"2015","unstructured":"Kamisawa T, Zen Y, Pillai S, Stone JH (2015) IgG4-related disease. Lancet 385(9976):1460\u20131471. https:\/\/doi.org\/10.1016\/S0140-6736(14)60720-0","journal-title":"Lancet"},{"issue":"7","key":"6377_CR21","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/art.39132","volume":"67","author":"A Khosroshahi","year":"2015","unstructured":"Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, Chari ST, Della-Torre E, Frulloni L, Goto H et al (2015) International consensus guidance statement on the management and treatment of igg4-related disease. Arthritis Rheumatol 67(7):1688\u20131699. https:\/\/doi.org\/10.1002\/art.39132","journal-title":"Arthritis Rheumatol"},{"issue":"Suppl 1","key":"6377_CR22","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1073\/pnas.0307513100","volume":"101","author":"C Chen","year":"2004","unstructured":"Chen C (2004) Searching for intellectual turning points: progressive knowledge domain visualization. Proc Natl Acad Sci U S A 101(Suppl 1):5303\u20135310. https:\/\/doi.org\/10.1073\/pnas.0307513100","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"6377_CR23","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1002\/art.34593","volume":"64","author":"JH Stone","year":"2012","unstructured":"Stone JH, Khosroshahi A, Deshpande V, Chan JK, Heathcote JG, Aalberse R, Azumi A, Bloch DB, Brugge WR, Carruthers MN et al (2012) Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum 64(10):3061\u20133067. https:\/\/doi.org\/10.1002\/art.34593","journal-title":"Arthritis Rheum"},{"issue":"8","key":"6377_CR24","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1002\/art.37999","volume":"65","author":"G Fatemi","year":"2013","unstructured":"Fatemi G, Fang MA (2013) IgG4-related pharyngitis-an addition to the nomenclature of IgG4-related disease: comment on the article by Stone et al. Arthritis Rheum. 65(8):2217. https:\/\/doi.org\/10.1002\/art.37999","journal-title":"Arthritis Rheum."},{"issue":"1","key":"6377_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10165-011-0508-6","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Sumida T, Mimori T, Tanaka Y et al (2012) A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 22(1):1\u201314. https:\/\/doi.org\/10.1007\/s10165-011-0508-6","journal-title":"Mod Rheumatol"},{"issue":"2","key":"6377_CR26","first-page":"109","volume":"105","author":"K Okazaki","year":"2014","unstructured":"Okazaki K (2014) Current concept, diagnosis and pathogenesis of autoimmune pancreatitis as IgG4-related disease. Minerva Med 105(2):109\u2013119","journal-title":"Minerva Med"},{"key":"6377_CR27","doi-asserted-by":"publisher","first-page":"357071","DOI":"10.1155\/2012\/357071","volume":"2012","author":"K Okazaki","year":"2012","unstructured":"Okazaki K, Umehara H (2012) Are classification criteria for IgG4-RD now possible? The concept of IgG4-related disease and proposal of comprehensive diagnostic criteria in Japan. Int J Rheumatol 2012:357071. https:\/\/doi.org\/10.1155\/2012\/357071","journal-title":"Int J Rheumatol"},{"issue":"9","key":"6377_CR28","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande V, Zen Y, Chan JKC, Yi EE, Sato Y, Yoshino T, Kloppel G, Heathcote JG, Khosroshahi A, Ferry JA et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25(9):1181\u20131192. https:\/\/doi.org\/10.1038\/modpathol.2012.72","journal-title":"Mod Pathol"},{"issue":"6","key":"6377_CR29","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA, Deshpande V, Smyrk TC, Chari S, Stone JH (2015) Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis 74(6):1171\u20131177. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206605","journal-title":"Ann Rheum Dis"},{"key":"6377_CR30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1146\/annurev-med-050219-034449","volume":"73","author":"G Katz","year":"2022","unstructured":"Katz G, Stone JH (2022) Clinical perspectives on IgG4-related disease and its classification. Annu Rev Med 73:545\u2013562. https:\/\/doi.org\/10.1146\/annurev-med-050219-034449","journal-title":"Annu Rev Med"},{"issue":"1","key":"6377_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.41145","volume":"72","author":"SR Johnson","year":"2020","unstructured":"Johnson SR, Bookman A (2020) Classification of IgG4-related disease: a medical marvel of our time. Arthritis Rheumatol 72(1):1\u20133. https:\/\/doi.org\/10.1002\/art.41145","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"6377_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/art.41120","volume":"72","author":"ZS Wallace","year":"2020","unstructured":"Wallace ZS, Naden RP, Chari S, Choi H, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A et al (2020) The 2019 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis Rheumatol 72(1):7\u201319. https:\/\/doi.org\/10.1002\/art.41120","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"6377_CR33","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.semarthrit.2021.04.021","volume":"51","author":"E Della-Torre","year":"2021","unstructured":"Della-Torre E, Lanzillotta M, Germano T, Mancuso G, Ramirez GA, Capurso G, Falconi M, Dagna L (2021) Utility of the \u201c2019 ACR\/EULAR classification criteria\u201d for the management of patients with IgG4-related disease. Semin Arthritis Rheum 51(4):761\u2013765. https:\/\/doi.org\/10.1016\/j.semarthrit.2021.04.021","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"6377_CR34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/14397595.2017.1290911","volume":"27","author":"H Umehara","year":"2017","unstructured":"Umehara H, Okazaki K, Nakamura T, Satoh-Nakamura T, Nakajima A, Kawano M, Mimori T, Chiba T (2017) Current approach to the diagnosis of IgG4-related disease - combination of comprehensive diagnostic and organ-specific criteria. Mod Rheumatol 27(3):381\u2013391. https:\/\/doi.org\/10.1080\/14397595.2017.1290911","journal-title":"Mod Rheumatol"},{"issue":"7","key":"6377_CR35","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/pin.12932","volume":"70","author":"A Satou","year":"2020","unstructured":"Satou A, Notohara K, Zen Y, Nakamura S, Yoshino T, Okazaki K, Sato Y (2020) Clinicopathological differential diagnosis of IgG4-related disease: a historical overview and a proposal of the criteria for excluding mimickers of IgG4-related disease. Pathol Int 70(7):391\u2013402. https:\/\/doi.org\/10.1111\/pin.12932","journal-title":"Pathol Int"},{"issue":"11","key":"6377_CR36","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1136\/jclinpath-2020-206733","volume":"73","author":"C Bruce-Brand","year":"2020","unstructured":"Bruce-Brand C, Schneider JW, Schubert P (2020) Rosai-Dorfman disease: an overview. J Clin Pathol 73(11):697\u2013705. https:\/\/doi.org\/10.1136\/jclinpath-2020-206733","journal-title":"J Clin Pathol"},{"issue":"10307","key":"6377_CR37","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/S0140-6736(21)01812-2","volume":"398","author":"LYC Chen","year":"2021","unstructured":"Chen LYC, Slack GW, Carruthers MN (2021) IgG4-related disease and Rosai-Dorfman-Destombes disease. Lancet 398(10307):1213\u20131214. https:\/\/doi.org\/10.1016\/S0140-6736(21)01812-2","journal-title":"Lancet"},{"issue":"1","key":"6377_CR38","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s13023-020-01567-6","volume":"15","author":"L Wang","year":"2020","unstructured":"Wang L, Li W, Zhang S, Peng L, Shen M, Song S, Zhang W, Cao X, Feng R, Zhang W (2020) Rosai-Dorfman disease mimicking IgG4-related diseases: a single-center experience in China. Orphanet J Rare Dis 15(1):285. https:\/\/doi.org\/10.1186\/s13023-020-01567-6","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"6377_CR39","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1309\/AJCPFH0SJ6YILXJU","volume":"140","author":"L Liu","year":"2013","unstructured":"Liu L, Perry AM, Cao W, Smith LM, Hsi ED, Liu X, Mo JQ, Dotlic S, Mosunjac M, Talmon G et al (2013) Relationship between Rosai-Dorfman disease and IgG4-related disease: study of 32 cases. Am J Clin Pathol 140(3):395\u2013402. https:\/\/doi.org\/10.1309\/AJCPFH0SJ6YILXJU","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"6377_CR40","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1309\/AJCPARC3YQ0KLIOA","volume":"139","author":"X Zhang","year":"2013","unstructured":"Zhang X, Hyjek E, Vardiman J (2013) A subset of Rosai-Dorfman disease exhibits features of IgG4-related disease. Am J Clin Pathol 139(5):622\u2013632. https:\/\/doi.org\/10.1309\/AJCPARC3YQ0KLIOA","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"6377_CR41","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1007\/s12664-020-01102-2","volume":"39","author":"HK Nayak","year":"2020","unstructured":"Nayak HK, Bhat SJ, Panigrahi MK, Chouhan I, Kumar C, Samal SC (2020) IgG4-related sclerosing cholangitis- a great mimicker. Indian J Gastroenterol 39(6):614\u2013618. https:\/\/doi.org\/10.1007\/s12664-020-01102-2","journal-title":"Indian J Gastroenterol"},{"issue":"3","key":"6377_CR42","doi-asserted-by":"publisher","first-page":"300","DOI":"10.5009\/gnl18085","volume":"13","author":"A Tanaka","year":"2019","unstructured":"Tanaka A (2019) IgG4-related sclerosing cholangitis and primary sclerosing cholangitis. Gut Liver 13(3):300\u2013307. https:\/\/doi.org\/10.5009\/gnl18085","journal-title":"Gut Liver"},{"issue":"1","key":"6377_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/jhbp.596","volume":"26","author":"T Kamisawa","year":"2019","unstructured":"Kamisawa T, Nakazawa T, Tazuma S, Zen Y, Tanaka A, Ohara H, Muraki T, Inui K, Inoue D, Nishino T et al (2019) Clinical practice guidelines for IgG4-related sclerosing cholangitis. J Hepatobiliary Pancreat Sci 26(1):9\u201342. https:\/\/doi.org\/10.1002\/jhbp.596","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"23","key":"6377_CR44","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.3748\/wjg.v26.i23.3126","volume":"26","author":"CD Manganis","year":"2020","unstructured":"Manganis CD, Chapman RW, Culver EL (2020) Review of primary sclerosing cholangitis with increased IgG4 levels. World J Gastroenterol 26(23):3126\u20133144. https:\/\/doi.org\/10.3748\/wjg.v26.i23.3126","journal-title":"World J Gastroenterol"},{"issue":"4","key":"6377_CR45","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1080\/14397595.2019.1705537","volume":"30","author":"T Borges","year":"2020","unstructured":"Borges T, Silva S (2020) IgG4-related disease: how to place it in the spectrum of immune-mediated and rheumatologic disorders? Mod Rheumatol 30(4):609\u2013616. https:\/\/doi.org\/10.1080\/14397595.2019.1705537","journal-title":"Mod Rheumatol"},{"key":"6377_CR46","doi-asserted-by":"publisher","first-page":"738540","DOI":"10.3389\/fimmu.2021.738540","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu J, Yin W, Westerberg LS, Lee P, Gong Q, Chen Y, Dong L, Liu C (2021) Immune dysregulation in IgG4-related disease. Front Immunol 12:738540. https:\/\/doi.org\/10.3389\/fimmu.2021.738540","journal-title":"Front Immunol"},{"issue":"11","key":"6377_CR47","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3899\/jrheum.150436","volume":"42","author":"J Asano","year":"2015","unstructured":"Asano J, Watanabe T, Oguchi T, Kanai K, Maruyama M, Ito T, Muraki T, Hamano H, Arakura N, Matsumoto A et al (2015) Association between immunoglobulin G4-related disease and malignancy within 12 years after diagnosis: an analysis after longterm followup. J Rheumatol 42(11):2135\u20132142. https:\/\/doi.org\/10.3899\/jrheum.150436","journal-title":"J Rheumatol"},{"issue":"10","key":"6377_CR48","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1136\/annrheumdis-2012-201694","volume":"71","author":"M Yamamoto","year":"2012","unstructured":"Yamamoto M, Takahashi H, Ishigami K, Yajima H, Shimizu Y, Tabeya T, Matsui M, Suzuki C, Naishiro Y, Imai K et al (2012) Relapse patterns in IgG4-related disease. Ann Rheum Dis 71(10):1755. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201694","journal-title":"Ann Rheum Dis"},{"key":"6377_CR49","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejim.2019.12.029","volume":"74","author":"C Campochiaro","year":"2020","unstructured":"Campochiaro C, Della-Torre E, Lanzillotta M, Bozzolo E, Baldissera E, Milani R, Arcidiacono PG, Crippa S, Falconi M, Dagna L (2020) Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease. Eur J Intern Med 74:92\u201398. https:\/\/doi.org\/10.1016\/j.ejim.2019.12.029","journal-title":"Eur J Intern Med"},{"issue":"8","key":"6377_CR50","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1093\/rheumatology\/kez669","volume":"59","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zeng Q, Zhu L, Gao J, Wang Z, Wang Z, Yang F, Wang K, Chen D, Xia C et al (2020) Relapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort. Rheumatology (Oxford) 59(8):2115\u20132123. https:\/\/doi.org\/10.1093\/rheumatology\/kez669","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"6377_CR51","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.pan.2021.06.009","volume":"21","author":"M Lanzillotta","year":"2021","unstructured":"Lanzillotta M, Della-Torre E, Wallace ZS, Stone JH, Karadag O, Fernandez-Codina A, Arcidiacono PG, Falconi M, Dagna L, Capurso G (2021) Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: a systematic review and meta-analysis. Pancreatology 21(7):1395\u20131401. https:\/\/doi.org\/10.1016\/j.pan.2021.06.009","journal-title":"Pancreatology"},{"issue":"3","key":"6377_CR52","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.reuma.2018.11.011","volume":"16","author":"L Betancur-Vasquez","year":"2020","unstructured":"Betancur-Vasquez L, Gonzalez-Hurtado D, Arango-Isaza D, Rojas-Villarraga A, Hernandez-Parra D, Carmona S, Diaz-Coronado JC (2020) IgG4-related disease: is rituximab the best therapeutic strategy for cases refractory to conventional therapy? Results of a systematic review. Reumatol Clin (Engl Ed) 16(3):195\u2013202. https:\/\/doi.org\/10.1016\/j.reuma.2018.11.011","journal-title":"Reumatol Clin (Engl Ed)"},{"issue":"5","key":"6377_CR53","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/1744666X.2021.1902310","volume":"17","author":"M Lanzillotta","year":"2021","unstructured":"Lanzillotta M, Fernandez-Codina A, Culver E, Ebbo M, Martinez-Valle F, Schleinitz N, Della-Torre E (2021) Emerging therapy options for IgG4-related disease. Expert Rev Clin Immunol 17(5):471\u2013483. https:\/\/doi.org\/10.1080\/1744666X.2021.1902310","journal-title":"Expert Rev Clin Immunol"},{"key":"6377_CR54","doi-asserted-by":"publisher","unstructured":"Backhus J, Neumann C, Perkhofer L, Schulte LA, Mayer B, Seufferlein T, Muller M, Kleger A (2021) A follow-up study of a European IgG4-related disease cohort treated with rituximab. J Clin Med.10(6). https:\/\/doi.org\/10.3390\/jcm10061329","DOI":"10.3390\/jcm10061329"},{"issue":"9","key":"6377_CR55","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1002\/art.39773","volume":"68","author":"ZS Wallace","year":"2016","unstructured":"Wallace ZS, Wallace CJ, Lu N, Choi HK, Stone JH (2016) Association of IgG4-related disease with history of malignancy. Arthritis Rheumatol 68(9):2283\u20132289. https:\/\/doi.org\/10.1002\/art.39773","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"6377_CR56","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s40744-021-00326-8","volume":"8","author":"Y Liu","year":"2021","unstructured":"Liu Y, Fu J, Ning X, Li H, Ma X, Wang K, Bian W, Zhang Y, Yu G, Li Z (2021) Malignancy risk of immunoglobin G4-related disease: evidence from a large cohort multicenter retrospective study. Rheumatol Ther. 8(3):1207\u20131221. https:\/\/doi.org\/10.1007\/s40744-021-00326-8","journal-title":"Rheumatol Ther."},{"issue":"1","key":"6377_CR57","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.1038\/s41598-020-61585-z","volume":"10","author":"H Tang","year":"2020","unstructured":"Tang H, Yang H, Zhang P, Wu D, Zhang S, Zhao J, Peng L, Chen H, Fei Y, Zhang X et al (2020) Malignancy and IgG4-related disease: the incidence, related factors and prognosis from a prospective cohort study in China. Sci Rep 10(1):4910. https:\/\/doi.org\/10.1038\/s41598-020-61585-z","journal-title":"Sci Rep"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06377-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06377-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06377-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T05:12:45Z","timestamp":1672981965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06377-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,19]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["6377"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06377-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,19]]},"assertion":[{"value":"29 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}